Nabriva Therapeutics' IPO

Nabriva Therapeutics raised a round of funding on September 18, 2015. Investors include Public.

Nabriva Therapeutics is a biotechnology company focused on developing a class of antibiotics, the pleuromutilins, for the treatment of patients with serious infections caused by multi-drug resistant p…

Articles about Nabriva Therapeutics' IPO: